Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort

Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort

The NUMEVOX cohort is intended to follow-up the macro and microvascular dysfunction in relation to adipose tissue repartition in patients with metabolic syndrome associated to liver steatosis, sleep apnea. Duration of the follow-up is 3 years for each patient entering the cohort.

Inclusion Criteria:

• informed consent
• age > 18 years old
• suspected of metabolic syndrome
• affiliated to french social health care

Exclusion Criteria:

• age < 18 years old
• pregnancy
• no informed consent
• not eligible for the study (no MS, cancer)